tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Holding VRDN?
Track your performance easily

Viridian Therapeutics (VRDN) Financial Statements

1,316 Followers

Viridian Therapeutics Financial Overview

Viridian Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.312; its P/E ratio is -4.67; Viridian Therapeutics is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 86.00K$ 72.00K$ 72.00K$ 72.00K$ 72.00K
Gross Profit$ 86.00K$ 72.00K$ 72.00K$ 72.00K$ 72.00K
EBIT$ -76.69M$ -64.99M$ -47.95M$ -65.94M$ -47.06M
EBITDA$ -76.49M$ -60.06M$ -47.81M$ -65.79M$ -46.92M
Net Income Common Stockholders$ -76.69M$ -64.40M$ -48.54M$ -66.86M$ -47.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 552.92M$ 463.70M$ 521.55M$ 374.54M$ 201.41M
Total Assets$ 771.90M$ 585.66M$ 630.38M$ 490.42M$ 328.76M
Total Debt$ 20.52M$ 20.45M$ 20.33M$ 20.20M$ 20.00M
Net Debt$ -532.40M$ -443.25M$ -501.22M$ -354.34M$ -181.41M
Total Liabilities$ 64.40M$ 56.33M$ 47.85M$ 48.40M$ 45.18M
Stockholders Equity$ 707.50M$ 401.06M$ 454.25M$ 442.02M$ 283.58M
Cash Flow-
Free Cash Flow$ -68.00M$ -46.16M$ -45.22M$ -38.05M$ -39.39M
Operating Cash Flow$ -67.71M$ -46.06M$ -45.22M$ -38.00M$ -38.98M
Investing Cash Flow$ -84.67M$ 61.98M$ -143.04M$ -169.71M$ 48.04M
Financing Cash Flow$ 245.02M$ 108.00K$ 177.08M$ 198.94M$ 15.46M
Currency in USD

Viridian Therapeutics Earnings and Revenue History

Viridian Therapeutics Debt to Assets

Viridian Therapeutics Cash Flow

Viridian Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis